---
layout: post
title: "Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels"
date: 2026-02-04 21:49:40 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2025-00425
original_published: 2025-01-16 00:00:00 +0000
significance: 8.00
---

# Mandatory Guidelines for Federal Workplace Drug Testing Programs-Authorized Testing Panels

**Published:** February 04, 2026 21:49 UTC
**Source:** Federal Register
**Original Published:** January 16, 2025 00:00 UTC
**Document Number:** 2025-00425

## Summary

The Department of Health and Human Services ("HHS" or "Department") herein publishes the panels of Schedule I and II drugs and biomarkers authorized for testing in Federal workplace drug testing programs. The Department has revised the drug testing panels for both urine and oral fluid, and revised required nomenclature for laboratory and Medical Review Officer Reports.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2025/01/16/2025-00425/mandatory-guidelines-for-federal-workplace-drug-testing-programs-authorized-testing-panels)
- API: https://www.federalregister.gov/api/v1/documents/2025-00425

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
